BioCatalyst

LXH254, LTT462, Trametinib, Ribociclib — catalyst calendar

1 verified catalyst event(s) referencing LXH254, LTT462, Trametinib, Ribociclib, each linked to its official source. Verified as of 2026-10-06.

Upcoming

DateEventCompanyDrugOfficial source & verification
2027-02-02
in 4mo
ESTIMATED
 READOUT
Study of Efficacy and Safety of LXH254 Combinations in Patients With Previously
Phase 2 · Melanoma
 NVS NOVARTIS AG LXH254, LTT462, Trametinib, Ribociclib ClinicalTrials.gov ↗
✓ Source-checked 2026-10-06
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.